The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere.
The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Drug-Device Combination Market forecasts from 2017-2027
• Revenue forecast for the drug-device combination market by End-Users: – Hospitals & clinics – Emergency service centers – Ambulatory surgical centers – Home care settings
Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World
• Revenue forecast for the drug-device combination market by Products: – Drug eluting stents – Photosensitizers – Orthopaedic products – Infusion pumps – Wound care products – Transmucosal products – Transdermal patches – Others
Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World
• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets: – North America: The U.S and Rest of North America – Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe – Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries – Rest of the world (RoW): Latin America, and Middle East and African countries
Each regional market is further divided by end-users and products
• This report discusses the leading companies in the global drug-device combination market: – Medtronic – Boston Scientific Corporation – Stryker Corporation – Ethicon Inc – C.R. Bard Inc. – Medline Industries Inc. – Mylan Inc. – Terumo Corporation – Pinnacle Biologics Inc. – W. L. Gore & Associates, Inc.
• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug-device combination market
Visiongain’s study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.
Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Global Drug-Device Combination Market Overview
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Drug-Device Combination Market Definition
2.1 What are Drug-Device Combination Products?
2.2 Types of Drug-Device Combination Products
2.2.1 Drug Eluting Stents
2.2.2 Photosensitizers
2.2.3 Orthopedic Products
2.2.4 Infusion Pumps
2.2.5 Wound Care Products
2.2.6 Transmucosal Products
2.2.7 Transdermal Products
2.3 Drug-Devices Combination Market Structure
2.4 Classification of Drug-Devices Combination Market
3. Drug-Device Combination Market: Global Market by End-Users 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
